Online citations, reference lists, and bibliographies.
← Back to Search

Optoacoustic Imaging Of The Breast: Correlation With Histopathology And Histopathologic Biomarkers

Gisela L. G. Menezes, R. Mann, C. Meeuwis, B. Bisschops, J. Veltman, P. Lavin, M. J. van de Vijver, R. Pijnappel
Published 2019 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
AimThis study was conducted in order to investigate the role of gray-scale ultrasound (US) and optoacoustic imaging combined with gray-scale ultrasound (OA/US) to better differentiate between breast cancer molecular subtypes.Materials and methodsAll 67 malignant masses included in the Maestro trial were retrospectively reviewed to compare US and OA/US feature scores and histopathological findings. Kruskal–Wallis tests were used to analyze the relationship between US and OA/US features and molecular subtypes of breast cancer. If a significant relationship was found, additional Wilcoxon–Mann–Whitney tests were used to identify the differences between molecular subtype groups.ResultsUS sound transmission helped to differentiate between LUMA and LUMB, LUMB and TNBC, and LUMB and all other molecular subtypes combined (p values < 0.05). Regarding OA/US features, the sum of internal features helped to differentiate between TNBC and HER2-enriched subtypes (p = 0.049). Internal vessels (p = 0.025), sum of all internal features (p = 0.019), and sum of internal and external features (p = 0.028) helped to differentiate between LUMA and LUMB. All internal features, the sum of all internal features, the sum of all internal and external features, and the ratio of internal and external features helped to differentiate between LUMA and TNBC. The same features also helped to differentiate between LUMA and TNBC from other molecular subtypes (p values < 0.05).ConclusionsThe use of OA/US might help radiologists to better differentiate between breast cancer molecular subtypes. Further studies need to be carried out in order to validate these results.Key Points• The combination of functional and morphologic information provided by optoacoustic imaging (OA) combined with gray-scale US helped to differentiate between breast cancer molecular subtypes.
This paper references
The assessment of angiogenesis and fibroblastic stromagenesis in hyperplastic and pre-invasive breast lesions
K. Pavlakis (2007)
Breast Cancer Molecular Subtype Prediction by Mammographic Radiomic Features.
W. Ma (2019)
Angiogenesis imaging.
J. Folkman (2000)
Triple-negative breast carcinoma: current and emerging concepts.
Robert Schmadeka (2014)
Δ Np 63 regulates the expression of hyaluronic acid - related genes in breast cancer cells
V Gatti
Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy
C. Herrero-Vicent (2017)
An inter-observer Ki67 reproducibility study applying two different assessment methods: on behalf of the Danish Scientific Committee of Pathology, Danish breast cancer cooperative group (DBCG)
A. Laenkholm (2018)
Is There a Correlation between the Presence of a Spiculated Mass on Mammogram and Luminal A Subtype Breast Cancer?
Song Liu (2016)
Cytologic features of triple‐negative breast carcinoma
M. Bonzanini (2012)
Latest world cancer statistics global cancer burden rises to 14.1 million new cases in 2012: marked increase in breast cancers must be addressed
The molecular profile of luminal B breast cancer
C. Creighton (2012)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
M. Cheang (2009)
Photoacoustic image patterns of breast carcinoma and comparisons with Magnetic Resonance Imaging and vascular stained histopathology
M. Heijblom (2015)
Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancers.
M. Boisserie-Lacroix (2013)
Breast Imaging Reporting and Data System
Samuel J. Magny (2020)
Pathological Characteristics of Triple-Negative Breast Cancer at Main Referral Teaching Hospital, April 2014 to April 2015, Tehran, Iran
A. Abdollahi (2016)
Molecular classification of infiltrating breast cancer: toward personalized therapy.
I. Trop (2014)
Breast-cancer screening.
C. Fox (1979)
MR Imaging Findings in Molecular Subtypes of Breast Cancer According to BIRADS System
Lidia Navarro Vilar (2017)
Histological types of breast cancer: How special are they?
B. Weigelt (2010)
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes
P. Maisonneuve (2014)
Current and Emerging Concepts
Robert Schmadeka (2014)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch (2013)
[Angiogenesis and breast cancer].
T. Bachelot (2007)
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.
S. Adams (2014)
2018)ΔNp63 regulates the expression of hyaluronic acid-related genes in breast cancer cells
V Gatti (2018)
FcRgamma activation regulates inflammation-associated squamous carcinogenesis.
P. Andreu (2010)
Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study.
M. V. Dieci (2014)
Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women
Wei-Tse Yang (2007)
Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.
P. Vaupel (1989)
Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging.
M. Mazurowski (2014)
Effect of screening and adjuvant therapy on mortality from breast cancer.
D. Berry (2005)
Tumor hypoxia: A target for selective cancer therapy
S. Kizaka-Kondoh (2003)
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
Catharina Medrek (2012)
Laser optoacoustic imaging system for detection of breast cancer.
S. Ermilov (2009)
Molecular and functional imaging of breast cancer
K. Glunde (2009)
Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
ACR BI-RADS® ultrasound
Eb B-Vm Mendelson (2013)
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
M. Ammirante (2010)
Role of angiogenesis in tumor growth and metastasis.
J. Folkman (2002)
Cancer survival in five continents: a worldwide population-based study (CONCORD).
M. Coleman (2008)
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
S. Badve (2011)
Breast imaging: A survey.
S. V. Sree (2011)
Interobserver variation in breast cancer grading: a statistical modeling approach.
N. Chowdhury (2006)
Predictive and prognostic impact of tumour-infiltrating lymphocytes in triplenegative breast cancer treated with neoadjuvant chemotherapy
C Herrero-Vicent (2017)
Mitosis Counting in Breast Cancer: Object-Level Interobserver Agreement and Comparison to an Automatic Method
M. Veta (2016)
Optoacoustic Breast Imaging: Imaging-Pathology Correlation of Optoacoustic Features in Benign and Malignant Breast Masses.
R. Butler (2018)
Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression.
Yingbing Wang (2008)
[Optoacoustic imaging].
M. Fournelle (2015)
A Pivotal Study of Optoacoustic Imaging to Diagnose Benign and Malignant Breast Masses: A New Evaluation Tool for Radiologists.
E. Neuschler (2018)
Tumor associated macrophages and neutrophils in tumor progression
M. R. Galdiero (2013)
Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma
T. Valković (2002)
Cytological Criteria for Predicting the Luminal Phenotype of Breast Carcinoma
Rafael Bispo Paschoalini (2016)
Molecular Imaging of Hypoxia
S. Chitneni (2011)
Malignant stroma increases luminal breast cancer cell proliferation and angiogenesis through platelet-derived growth factor signaling
M. Pinto (2014)
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent.
K. D. de Visser (2005)
Exploiting tumour hypoxia in cancer treatment
J. M. Brown (2004)
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
C. Livasy (2006)
CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages.
D. DeNardo (2009)
Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes
A. Prat (2013)
ΔNp63 regulates the expression of hyaluronic acid-related genes in breast cancer cells
Veronica Gatti (2018)
Downgrading of Breast Masses Suspicious for Cancer by Using Optoacoustic Breast Imaging.
G. L. Menezes (2018)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar